Clinical trial
Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial
NCT00794573 is registered in ClinicalTrials.gov with Mark Eisenberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial
- Lead sponsor
- Mark Eisenberg
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- December 31, 2015
- Enrollment
- 302 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.